Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis.

Saved in:
Bibliographic Details
Title: Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis.
Authors: Shragai T; Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. tamirsh@tlvmc.gov.il.; Gray Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. tamirsh@tlvmc.gov.il., Ganayem M; Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel., Cohen YC; Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Gray Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Avivi I; Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Gray Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Lebel E; Department of Hematology, Hadassah Medical Center, Jerusalem, Israel.; Hadassah Medical School, Hebrew University, Jerusalem, Israel., Even-Gross Zohar N; Department of Hematology, Hadassah Medical Center, Jerusalem, Israel.; Hadassah Medical School, Hebrew University, Jerusalem, Israel., Melamed N; Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel., Gatt ME; Department of Hematology, Hadassah Medical Center, Jerusalem, Israel.; Hadassah Medical School, Hebrew University, Jerusalem, Israel.
Source: Annals of hematology [Ann Hematol] 2026 Mar 12; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 12.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0584
DOI:10.1007/s00277-026-06931-3